3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Classical hematology
1
Conditions
Neoplasms
5
Healthy Participants
5
Breast Neoplasms
5
Prostatic Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Venous Thromboembolism
2
Solid Tumor, Adult
2
Neoplasm Metastasis
2
Healthy Volunteers
2
Endometrial Neoplasms
2
Colorectal Neoplasms
2
Cardiovascular Diseases
2
cMET-dysregulated Advanced Solid Tumors
1
Venous Thrombosis
1
TP53 Y220C Mutation
1
Stroke
1
Sarcoma, Synovial
1
Sarcoma, Alveolar Soft Part
1
Sarcoma
1
Rectal Neoplasms
1
Pulmonary Embolism
1
Prostatic Neoplasms, Castration-Resistant
1
Precancerous Conditions
1
Peripheral Nervous System Diseases
1
Pain
1
Ovarian Neoplasms
1
Multiple Endocrine Neoplasia Type 1
1
Melanoma
1
Liver Cirrhosis
1
Leiomyosarcoma
1
Interventions
Dalteparin
10
apixaban
9
Tinzaparin
4
Enoxaparin
4
Heparin, Low-Molecular-Weight
3
edoxaban
2
abelacimab
2
Rivaroxaban
2
MAA868
2
Dabigatran
2
perflutren
1
isoquercitrin
1
enoxaparin sodium
1
bemiparin
1
Warfarin
1
Sulfur Hexafluoride
1
Rosuvastatin Calcium
1
Hospitals
1
Fondaparinux
1
Fluorodeoxyglucose F18
1
Educational Status
1
Deoxyribonucleases
1
Acetylcysteine
1
4-((1,4,8,11-tetraazacyclotetradec-1-yl)methyl)benzoic acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Pulmonary Embolism
×
Rosuvastatin Calcium
×
Clear all
NCT07303816
2026-06-01
STAT-CAT
Brigham and Women's Hospital
Phase 4
Not yet recruiting
4,000 enrolled